Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1–August 20, 2021): a retrospective observational monocentric study

Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1–August 20, 2021): a retrospective observational monocentric study

Abstract Background Monoclonal antibodies (mAb) prevent COVID-19 progression when administered early. We compared mAb treatment outcomes among vaccinated and unvaccinated patients during Delta wave and assessed the feasibility of implementing stricter eligibility criteria in the event of mAb scarcit...

Full description

Bibliographic Details
Main Authors: Yi Guo, Kelsie Cowman, Mei Chang, Hongkai Bao, Austin Golia, Terrence Mcsweeney, Linda Bard, Roxanne Simpson, Erin Andrews, Liise-anne Pirofski, Priya Nori
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Infectious Diseases
Subjects:
Coronavirus disease 19
COVID-19
Delta variant
SARS-CoV-2 variant B.1.617.2
Monoclonal antibody
Casirivimab/imdevimab
Online Access:https://doi.org/10.1186/s12879-022-07626-6

Internet

https://doi.org/10.1186/s12879-022-07626-6

Similar Items